Cannasouth

Cannasouth is a biopharmaceutical research and development company based in Waikato, New Zealand. The company has been established to focus on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. The goal is the development of next-generation cannabinoid medicines that support patients' health outcomes and improve quality of life. Cannasouth products will be produced under GMP & ISO using environmentally friendly methods without the use of harmful chemicals or solvents, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.


Company Details

Registered Office: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216
Postal Address: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216
Telephone: +64-7-949-8393
Facsimile: n/a
Website: https://cannasouth.co.nz/
First Listed: 19/06/2019
Balance Date: 31 December
AGM: 30/06/2023

Directors and Executives

Colin Foster
CFO / Company Secretary
Anthony Ho
Independent Chairman
Mark Lucas
Chief Executive Officer
Gregory Misson
Executive Director
Christine Pears
Independent Non-Executive Director
Mark Scapens
Independent Non-Executive Director
Hilary Webber
Independent Non-Executive Director

Announcements

Title Date Type
Recording and Presentation of Investor Call Thu, Nov 30 2023 10:21 am MKTUPDTE
Cannasouth Investor Call Mon, Nov 27 2023 03:13 pm GENERAL
Cannasouth Announces Opening of Rights Offer Wed, Nov 22 2023 09:13 am OFFER
Launch of rights issue and revenue guidance Mon, Nov 13 2023 01:57 pm OFFER
CBD to Issue up to $5 million in Secured Convertible Notes Thu, Nov 02 2023 04:11 pm ADMIN
Cannasouth to Sell Verified Dried Cannabis Flower Tue, Oct 31 2023 09:00 am MKTUPDTE
Successful Verification for Oral Solution Products Fri, Oct 27 2023 02:15 pm MKTUPDTE
Cannasouth Announces Integration Restructure Tue, Oct 03 2023 08:30 am MKTUPDTE
Cannasouth exports first Cannabis-based API Thu, Sep 14 2023 08:30 am MKTUPDTE
Publication of Research Report Mon, Sep 04 2023 11:47 am MKTUPDTE

Major Holdings Announcements

Date Name No. Held % Current
08/06/23 Mark Lucas 28,029,435 27.60 8.74
14/02/22 Nicholas Jon Foreman 24,162,149 21.07 17.61
11/03/20 Adam Sorensen 5,165,563 6.14 4.89

Director’s Interests Announcements

Date Name No. Held % Details Other
08/06/23 Anthony Ho 2,067,338 - - -
08/06/23 Christine Pears 110,000 - - -
08/06/23 Hilary Webber. 2,710,425 - - -
15/09/22 Juliet Hull 28,766 - - -
10/08/21 Colin Foster 250,000 - - -
23/10/20 Conor English 4,741 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 06/06/2023


Markets News

NZ sharemarket lifts into positive territory for the year
Markets Market close

NZ sharemarket lifts into positive territory for the year

The S&P/NZX 50 Index closed at 11,496.61, up 33.12 points or 0.29%.

Markets

Air NZ’s 'small but mighty' step towards green aviation

The carrier has bought an all-electric aircraft from Beta Tech, to be delivered in 2026.

Air NZ’s 'small but mighty' step towards green aviation
Markets

Xero, Tourism Holdings, NZME among Deloitte Top 200 winners

The prestigious Deloitte Top 200 Awards winners were revealed on Wednesday evening.

Xero, Tourism Holdings, NZME among Deloitte Top 200 winners
Markets

ComCom: Is it time to deregulate fibre broadband?

The review is the first under a new regulatory regime.

ComCom: Is it time to deregulate fibre broadband?
Finance

Fonterra lifts payout, earning forecast

The lift comes after the recent lift in global prices.

Fonterra lifts payout, earning forecast